Peanut immunotherapy: what to know

For peanut allergy, immunotherapy exposes a person to carefully measured peanut protein under specialist supervision, with the aim of changing how the immune system responds to accidental exposure. It is not the same as eating peanuts independently and does not replace an emergency action plan.

In oncology, immunotherapy is a group of treatments that may help immune cells recognise or attack cancer. It can be used for selected cancers, including bladder, cervical, bowel, head and neck, liver, lung, and some blood cancers or melanomas. The treatment choice depends on the cancer type, its features, previous treatment, and the person's health.

Clarify whether the discussion concerns peanut allergy or cancer treatment before reviewing options. Ask what medicine or protocol is being proposed, where it is given, how monitoring works, and which existing medicines or immune conditions should be disclosed. Keep allergy and oncology plans separate because their goals, dosing, and safety instructions differ.

During allergy treatment, urgent symptoms such as breathing difficulty, throat tightness, faintness, or widespread swelling need emergency action according to the prescribed plan. During cancer immunotherapy, promptly report new or worsening breathing, severe diarrhoea, marked rash, yellowing of the skin, confusion, or unusual weakness because immune effects can affect different organs.

Ask which type of immunotherapy is meant, what outcome it targets, how it will be monitored, which symptoms require urgent help, and whether the treatment changes your current allergy or cancer medicines.